Skin equivalent: An attractive model to evaluate early melanoma metastasis

Melanoma Research

Volumn 10, Issue 2, 2000, Pages 127-140

  Dekker, S K ^a   Van Doorn, R ^a   Kempenaar, J ^a   Gruis, N A ^a   Vermeer, B J ^a   Ponec, M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

E cadherin; Integrin; Invasion; Keratinocyte; Melanoma; Skin equivalent model

Indexed keywords

INTEGRIN; UVOMORULIN;

ARTICLE; CANCER GROWTH; CANCER INVASION; CELL INTERACTION; COCULTURE; DERMIS; EPIDERMIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MELANOMA CELL; METASTASIS POTENTIAL; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034017889     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200004000-00005     Document Type: Article

References (47)

1. 1. Fitzpatrick T, Breathnach A. Das epidermal Melanin-Einheit System. Dermatol Wochenschr 1963; 147: 481-489.
2. 2. Bertaux B, Morliere P, Moreno G, Courtalon A, Masse JM, Dubertret L. Growth of melanocytes in a skin equivalent model in vitro. Br J Dermatol 1988; 119: 503-512.
3. 3. De Luca M, Pellegrini G, Zambruno G, Marchisio PC. Role of integrins in cell adhesion and polarity in normal keratinocytes and human skin pathologies. J Dermatol 1994; 21: 821-828.
4. 4. Valyi-Nagy IT, Hirka G, Jensen PJ, Shih IM, Juhasz I, Herlyn M. Undifferentiated keratinocytes control growth, morphology, and antigen expression of normal melanocytes through cell-cell contact. Lab Invest 1993; 69: 152-159.
5. 5. Weterman MA, van Muijen GN, Bloemers HP, Ruiter DJ. Molecular markers of melanocytic tumor progression. Lab Invest 1994; 70: 593-608.
6. 6. Hsu MY, Shih DT, Meier FE, et al. Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. Am J Pathol 1998; 153: 1435-1442.
7. 7. Albelda SM. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 1993; 68: 4-17.
8. 8. Holzmann B, Gosslar U, Bittner M. Alpha 4 integrins and tumor metastasis. Curr Topics Microbiol Immunol 1998; 231: 125-141.
9. 9. Moretti S, Martini L, Berti E, Pinzi C, Giannotti B. Adhesion molecule profile and malignancy of melanocytic lesions. Melanoma Res 1993; 3: 235-239.
10. 10. Vink J, Thomas L, Etoh T, et al. Role of beta-1 integrins in organ specific adhesion of melanoma cells in vitro. Lab Invest 1993; 68: 192-203.
11. 11. Shih IM, Speicher D, Hsu MY, Levine E, Herlyn M. Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion. Cancer Res 1997; 57: 3835-3840.
12. 12. Olden K. Adhesion molecules and inhibitors of glycosylation in cancer. Semin Cancer Biol 1993; 4: 269-276.
13. 13. Rucklidge GJ, Edvardsen K, Bock E. Cell-adhesion molecules and metalloproteinases: a linked role in tumour cell invasiveness. Biochem Soc Trans 1994; 22: 63-68.
14. 14. Andalib AR, Lawry J, Ali SA, et al. Cytokine modulation of antigen expression in human melanoma cell lines derived from primary and metastatic tumour tissues. Melanoma Res 1997; 7: 32-42.
15. 15. Dekker SK, Vink J, Vermeer BJ, Bruijn JA, Mihm MC Jr, Byers HR. Differential effects of interleukin 1-alpha (IL-I alpha) or tumor necrosis factor-alpha (TNF-alpha) on motility of human melanoma cell lines on fibronectin. J Invest Dermatol 1994; 102: 898-905.
16. 16. Garofalo A, Chirivi RG, Foglieni C, et al. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases. Cancer Res 1995; 55: 414-419.
17. 17. Tang A, Eller MS, Hara M, Yaar M, Hirohashi S, Gilchrest BA. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci 1994; 107: 983-992.
18. 18. Ponec M, Weerheim A, Kempenaar J, Mommaas AM, Nugteren DH. Lipid composition of cultured human keratinocytes in relation to their differentiation. J Lipid Res 1988, 29: 949-961.
19. 19. Byers HR, Etoh T, Doherty JR, Sober AJ, Mihm MC Jr. Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time-lapse and image analysis. Am J Pathol 1991; 139: 423-435.
20. 20. Carrel S, Schreyer M, Giuffre L. Melanoma associated differentiation antigens: investigation with monoclonal antibodies. Prog Clin Biol Res 1988; 256: 585-595.
21. 21. Loeffel SC, Gillespie GY, Mirmiran SA, et al. Cellular immunolocalization of S100 protein within fixed tissue sections by monoclonal antibodies. Arch Pathol Lab Med 1985; 109: 117-122.
22. 22. Horton MA, Lewis D, McNulty K, Pringle JA, Chambers TJ. Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. Cancer Res 1985; 45: 5663-5669.
23. 23. Davies J, Warwick J, Totty N, Philp R, Helfrich M, Horton M. The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J Cell Biol 1989; 109: 1817-1826.
24. 24. Stender IM, Etoh T, Tsuchida T, et al. Metastatic behavior and tumorigenicity of a human melanoma cell line (MM-RU) after injection into nude mice. J Dermatol 1993; 20: 611-617.
25. 25. Ansel J, Perry P, Brown J, et al. Cytokine modulation of keratinocyte cytokines. J Invest Dermatol 1990; 94: 101S-107S.
26. 26. Hart IR, Birch M, Marshall JF. Cell adhesion receptor expression during melanoma progression and metastasis. Cancer Metastasis Rev 1991; 10: 115-128.
27. 27. Delcommenne M, Streuli CH. Control of integrin expression by extracellular matrix. J Biol Chem 1995; 270: 26794-26801.
28. 28. Anichini A, Mortarini R, Berti E, Parmiani G. Multiple VLA antigens on a subset of melanoma clones. Hum Immunol 1990; 28: 119-122.
29. 29. Mortarini R, Anichini A. From adhesion to signalling: roles of integrins in the biology of human melanoma. Melanoma Res 1993; 3: 87-97.
30. 30. Schadendorf D, Heidel J, Gawlik C, Suter L, Czarnetzki BM. Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J Natl Cancer Inst 1995; 87: 366-371.
31. 31. Bracke ME, Depypere H, Labit C, et al. Functional downregulation of the E-cadherin/catenin complex leads to loss of contact inhibition of motility and of mitochondrial activity, but not of growth in confluent epithelial cell cultures. Eur J Cell Biol 1997; 74: 342-349.
32. 32. Hsu MY, Wheelock MJ, Johnson KR, Herlyn M. Shifts in cadherin profiles between human normal melanocytes and melanomas. J Invest Dermatol Symp Proc 1996; 1: 188-194.
33. 33. Danen EH, de Vries TJ, Morandini R, Ghanem GG, Ruiter DJ, van Muijen GN. E-cadherin expression in human melanoma. Melanoma Res 1996; 6: 127-131.
34. 34. Schadendorf D, Gawlik C, Haney U, Ostmeier H, Suter L, Czarnetzki BM. Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours. J Pathol 1993; 170: 429-434.
35. 35. Albelda SM, Mette SA, Elder DE, et al. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res 1990; 50: 6757-6764.
36. 36. Mortarini R, Anichini A, Parmiani G. Heterogeneity for integrin expression and cytokine-mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins. Int J Cancer 1991; 47: 551-559.
37. 37. Klein CE, Steinmayer T, Kaufmann D, Weber L, Brocker EB. Identification of a melanoma progression antigen as integrin VLA-2. J Invest Dermatol 1991; 96: 281-284.
38. 38. Danen EH, van Muijen GN, van de Wiel-van Kemenade E, Jansen KF, Ruiter DJ, Figdor CG. Regulation of integrin-mediated adhesion to laminin and collagen in human melanocytes and in non-metastatic and highly metastatic human melanoma cells. Int J Cancer 1993; 54: 315-321.
39. 39. Natali PG, Nicotra MR, Bartolazzi A, Cavaliere R, Bigotti A. Integrin expression in cutaneous malignant melanoma: association of the alpha 3/beta 1 heterodimer with tumor progression. Int J Cancer 1993; 54: 68-72.
40. 40. Melchiori A, Mortarini R, Carlone S, et al. The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion. Exp Cell Res 1995; 219: 233-242.
41. 41. Gehlsen KR, Davis GE, Sriramarao P. Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin Exp Metastasis 1992; 10: 111-120.
42. 42. Seftor RE, Seftor EA, Stetler-Stevenson WG, Hendrix MJ. The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion. Cancer Res 1993; 53: 3411-3415.
43. 43. Natali PG, Nicotra MR, Cavaliere R, Giannarelli D, Bigotti A. Tumor progression in human malignant melanoma is associated with changes in alpha 6/beta 1 laminin receptor. Int J Cancer 1991; 49: 168-172.
44. 44. Van Belle PA, Elenitsas R, Satyamoorthy K, et al. Progression-related expression of beta3 integrin in melanomas and nevi. Hum Pathol 1999; 30: 562-567.
45. 45. Felding-Habermann B, Mueller BM, Romerdahl CA, Cheresh DA. Involvement of integrin alpha V gene expression in human melanoma tumorigenicity. J Clin Invest 1992; 89: 2018-2022.
46. 46. Qian F, Vaux DL, Weissman IL. Expression of the integrin alpha 4 beta 1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell 1994; 77: 335-347.
47. 47. Boukerche H, Benchaibi M, Berthier-Vergnes O, Lizard G, Bailly M, McGregor JL. Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the beta 3 integrin subunit. Eur J Biochem 1994; 220: 485-491.